GlassScriptPhysician profile
Ronak B Jani
NPI 1417182304
$86,741.22
in general payments reported to CMS, 2019-2025
58 companies · $15K in 2025
The $15K reported for 2025 was more than what 91% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,107 · 2020: $2,344 · 2021: $19K · 2022: $27K · 2023: $12K · 2024: $8,959 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $23K · Food and Beverage: $12K · Education: $122 · Travel and Lodging: $11.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $23,206.25 |
| Food and Beverage | $11,989.69 |
| Education | $122.33 |
| Travel and Lodging | $11.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $64,021.54 | 2021-2025 | |
| Ucb, INC. | $3,310.83 | 2019-2025 | Briviact, Rystiggo, Fintepla |
| Allergan, INC. | $1,752.29 | 2019-2022 | |
| Amgen INC. | $1,394.36 | 2019-2025 | Aimovig, Uplizna |
| Sk Life Science, INC. | $1,132.96 | 2020-2025 | Xcopri |
| Novartis Pharmaceuticals Corporation | $1,087.77 | 2019-2025 | |
| Pfizer INC. | $1,054.95 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $926.78 | 2019-2025 | Austedo Xr, Ajovy, Austedo Xr |
| Lilly USA, LLC | $876.80 | 2019-2025 | Amyvid, Emgality, Kisunla |
| Supernus Pharmaceuticals, INC. | $869.38 | 2019-2025 | Qelbree |
| Mdd US Operations, LLC | $820.04 | 2019-2025 | Gocovri, Gocovri |
| Jazz Pharmaceuticals INC. | $815.75 | 2022-2025 | |
| Acadia Pharmaceuticals INC | $749.33 | 2019-2025 | Nuplazid |
| Argenx US, INC. | $690.98 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
| Biohaven Pharmaceutical Holding Company LTD. | $539.39 | 2022 |
Show all 58 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $524.77 | 2021 | |
| Neurocrine Biosciences, INC. | $460.26 | 2020-2025 | Ingrezza |
| Lundbeck LLC | $455.77 | 2019-2025 | Vyepti, Rexulti |
| Eisai INC. | $399.05 | 2019-2025 | |
| Livanova USA, INC. | $386.27 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Sunovion Pharmaceuticals INC. | $336.91 | 2019-2022 | |
| Neurelis, INC. | $307.21 | 2020-2025 | Valtoco |
| Biogen, INC. | $302.07 | 2021-2025 | Leqembi, Vumerity, Plegridy |
| Adamas Pharmaceuticals, INC. | $278.55 | 2019-2021 | |
| Boston Scientific Corporation | $265.01 | 2020-2025 | Vercise, General - Dbs |
| Takeda Pharmaceuticals U.S.A., INC. | $232.38 | 2023-2025 | Hyqvia |
| Astrazeneca Pharmaceuticals LP | $226.02 | 2021-2023 | Andexxa |
| Amneal Pharmaceuticals LLC | $196.19 | 2021-2025 | Crexont, Rytary |
| Arbor Pharmaceuticals, INC. | $182.48 | 2019-2022 | |
| Impel Pharmaceuticals INC. | $168.96 | 2022-2023 | Trudhesa |
| Azurity Pharmaceuticals, INC. | $163.82 | 2023-2025 | Horizant, Horizant |
| Janssen Biotech, INC. | $162.08 | 2025 | |
| Akcea Therapeutics, INC. | $159.13 | 2019-2020 | |
| Grifols USA, LLC | $152.18 | 2019-2020 | |
| Assertio Therapeutics, INC. | $146.76 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $118.91 | 2019-2024 | Onpattro |
| Aprecia Pharmaceuticals, LLC | $118.58 | 2020-2022 | |
| Sumitomo Pharma America, INC. | $100.41 | 2023-2024 | Aptiom |
| Acorda Therapeutics, INC | $99.23 | 2019-2021 | |
| Avion Pharmaceuticals | $81.66 | 2022 | |
| Scilex Pharmaceuticals INC. | $78.22 | 2023-2024 | Ztlido |
| Otsuka America Pharmaceutical, INC. | $64.17 | 2023-2025 | Rexulti, Nuedexta |
| Janssen Pharmaceuticals, INC | $58.83 | 2022 | |
| Tg Therapeutics, INC. | $55.71 | 2023-2024 | |
| Vanda Pharmaceuticals INC. | $50.03 | 2024-2025 | Ponvory |
| Idorsia Pharmaceuticals US INC | $48.99 | 2022-2023 | Quviviq |
| Genzyme Corporation | $45.57 | 2021 | |
| Avanir Pharmaceuticals, INC. | $35.02 | 2022 | |
| Catalyst Pharmaceuticals, INC. | $34.56 | 2022 | |
| Upsher-Smith Laboratories LLC | $28.43 | 2019-2020 | |
| Currax Pharmaceuticals LLC | $26.43 | 2022-2024 | Onzetra Xsail |
| Abbott Laboratories | $25.85 | 2025 | Infinity |
| Sanofi-Aventis U.S. LLC | $24.64 | 2020 | |
| Nevro Corp. | $24.25 | 2024 | Senza |
| Impel Pharmaceuticals LLC | $23.43 | 2025 | Trudhesa |
| Inspire Medical Systems, INC. | $17.82 | 2024 | Inspire |
| Aucta Pharmaceuticals, INC. | $16.99 | 2025 | Motpoly Xr |
| Kyowa Kirin, INC. | $14.47 | 2024 | Nourianz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronak Jani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.